Brain stimulation for mood problems after COVID-19
Part of Infections, Mental health clinical trials.
This study tests if repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, can help people aged 18 to 65 who have ongoing depression or low mood for more than 12 weeks after a confirmed COVID-19 infection. The treatment uses magnetic pulses to gently stimulate parts of the brain involved in mood regulation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have had a confirmed COVID-19 infection (by a PCR test or antibody test).
- You must still have depression symptoms (scoring 15 or higher on a standard depression scale) lasting more than 12 weeks since your COVID infection.
- You must have no history of mental health problems before your COVID infection.
- You cannot have any major medical conditions (like kidney failure, liver disease, heart failure, or heart disease) or substance use disorder.
- You cannot have any metal devices near your head (like cochlear implants or certain implants), a history of seizures, strokes, or head injuries.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether accelerated TMS (a brain stimulation treatment) can help people with depression who also have long COVID. It may be an option if your depression hasn't improved enough with medication alone.
This trial tests whether a non-invasive brain treatment called rTMS (repetitive transcranial magnetic stimulation) can help with the severe fatigue and brain fog that often come with long COVID. You would need to be able to come to the hospital for multiple treatment sessions.
This trial tests whether a non-surgical brain stimulation technique (rTMS) can reduce depression symptoms in adults with major depression. You would likely have several study visits that include brain scans (MRI) and treatment sessions to see if symptoms improve.
This study tests how a specific kind of brain stimulation (repetitive transcranial magnetic stimulation) works for people with depression that has not responded to standard treatments. If you qualify, it may help doctors understand the mechanism and improve options for treatment-resistant depression.
This study uses a special type of brain stimulation (rTMS, which uses magnetic pulses) to treat depression. It focuses on part of the brain called the orbitofrontal cortex and aims to understand how stimulating it helps improve mood.
This study tests repeated brain stimulation (rTMS) to see if it can improve symptoms of schizophrenia and related depression, and measure body/brain changes. You may be considered if you have schizophrenia or schizoaffective disorder with enough depressive symptoms, and if recent treatments and medical safety factors fit the rules.
Hear when a new Post COVID -19 Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.